Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03298087
Title Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors VA Office of Research and Development

prostate adenocarcinoma


Abiraterone + Apalutamide + Leuprolide

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.